Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:3191-3198
Published online before print June 16, 2003, doi: 10.1161/01.CIR.0000074227.53616.CC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/25/3191    most recent
01.CIR.0000074227.53616.CCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDermott, M. M.
Right arrow Articles by Fornage, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDermott, M. M.
Right arrow Articles by Fornage, M.
Related Collections
Right arrow Peripheral vascular disease
Right arrow Epidemiology
Right arrow Coagulation and fibronolysis
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2003;107:3191.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

D-Dimer, Inflammatory Markers, and Lower Extremity Functioning in Patients With and Without Peripheral Arterial Disease

Mary McGrae McDermott, MD; Philip Greenland, MD; David Green, MD, PhD; Jack M. Guralnik, MD, PhD; Michael H. Criqui, MD, MPH; Kiang Liu, PhD; Cheeling Chan, MS; William H. Pearce, MD; Lloyd Taylor, MD; Paul M Ridker, MD; Joseph R. Schneider, MD, PhD; Gary Martin, MD; Nader Rifai, PhD; Maureen Quann, BS; Myriam Fornage, PhD

From the Departments of Medicine (M.M.M., P.G., D.G., G.M., M.Q., P.M.R.), Preventive Medicine (M.M.M., P.G., K.L., C.C.), and Surgery (W.H.P., J.R.S.), Northwestern University’s Feinberg School of Medicine, Chicago, Ill; National Institute on Aging (J.M.G.), Bethesda, Md; University of California at San Diego (M.H.C.), San Diego, Calif; Oregon Health and Science University (L.T.), Portland, Ore; Harvard Medical School (P.M.R., N.R.), Boston, Mass; Department of Surgery, Evanston Hospital (J.R.S.), Evanston, Ill; and University of Texas at Houston (M.F.), Houston, Tex.

Correspondence to Dr McDermott, 675 N St Clair, Suite 18-200, Chicago, IL 60611. E-mail mdm608{at}northwestern.edu

Background— We determined whether higher levels of D-dimer, C-reactive protein (CRP), fibrinogen, and serum amyloid A are associated independently with functional impairment in patients with and without peripheral arterial disease (PAD).

Methods and Results— Participants were 370 men and women with PAD (ankle brachial index <0.90) and 231 without PAD. Functional outcomes were 6-minute walk distance and 4-meter walking velocity. A summary performance score combined performance in walking speed, standing balance, and time for 5 repeated chair rises into an ordinal score ranging from 0 to 12 (12=best). Adjusting for age, sex, ankle brachial index, comorbidities, and other potential mediators and confounders, D-dimer levels were associated independently and inversely with performance on all 3 functional measures in the entire cohort and among patients with and without PAD, respectively. Adjusting for known and potential confounders, CRP levels were associated independently with 6-minute walk distance and the summary performance score among participants with PAD. No significant associations were observed between CRP and the functional measures among participants without PAD. Fibrinogen and SAA levels were not associated independently with the functional measures.

Conclusions— Higher D-dimer levels are associated with poorer functioning among individuals with and without PAD. Higher CRP levels were associated with poorer 6-minute walk performance and a lower summary performance score among participants with PAD but not among those without PAD. Additional study is needed to determine whether D-dimer and CRP are involved in the pathophysiology of functional impairment or whether they are simply sensitive markers of the extent of systemic atherosclerosis.


Key Words: coagulation • fibrinolysis • epidemiology • peripheral vascular disease • claudication




This article has been cited by other articles:


Home page
Vasc MedHome page
L. M. Reich, G. Heiss, L. L. Boland, A. T. Hirsch, K. Wu, and A. R. Folsom
Ankle brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort
Vascular Medicine, November 1, 2007; 12(4): 267 - 273.
[Abstract] [PDF]


Home page
Vasc MedHome page
S. Haugen, I. P. Casserly, J. G. Regensteiner, and W. R. Hiatt
Risk assessment in the patient with established peripheral arterial disease
Vascular Medicine, November 1, 2007; 12(4): 343 - 350.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
C. Monaco, E. Rossi, D. Milazzo, F. Citterio, F. Ginnetti, G. D'Onofrio, D. Cianflone, F. Crea, L. M. Biasucci, and A. Maseri
Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden
J. Am. Coll. Cardiol., January 18, 2005; 45(2): 238 - 243.
[Abstract] [Full Text] [PDF]